$7.5 million grant awarded for glaucoma research

The German state of Saxony has granted a $7.5 million grant to Mannin, a technology partner of Q BioMed Inc., to develop novel pharmaceuticals and biologic treatments for glaucoma, according to a press release.
Mannin and Q BioMed are working together to accelerate the development of glaucoma therapies, leveraging two modes of action to reduce intraocular pressure, different routes of administration and different dosing regimens, the release said.
"We are thrilled that we will be able to speed the development of these promising therapeutics and bring new innovation to glaucoma (Read more...)

Full Story →